{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2",
      "covid-19",
      "reactivation",
      "reinfection",
      "vaccine"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33393854",
  "DateCompleted": {
    "Year": "2021",
    "Month": "01",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1080/21645515.2020.1830683"
    ],
    "Journal": {
      "ISSN": "2164-554X",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "12",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec",
          "Day": "01"
        }
      },
      "Title": "Human vaccines & immunotherapeutics",
      "ISOAbbreviation": "Hum Vaccin Immunother"
    },
    "ArticleTitle": "SARS-CoV-2 reinfection and implications for vaccine development.",
    "Pagination": {
      "StartPage": "3061",
      "EndPage": "3073",
      "MedlinePgn": "3061-3073"
    },
    "Abstract": {
      "AbstractText": [
        "Coronavirus disease 2019 (COVID-19) pandemic continues to constitute a public health emergency of international concern. Multiple vaccine candidates for COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have entered clinical trials. However, some evidence suggests that patients who have recovered from COVID-19 can be reinfected. For example, in China, two discharged COVID-19 patients who had recovered and fulfilled the discharge criteria for COVID-19 were retested positive to a reverse transcription polymerase chain reaction (RT-PCR) assay for the virus. This finding is critical and could hamper COVID-19 vaccine development. This review offers literature-based evidence of reinfection with SARS-CoV-2, provides explanation for the possibility of SARS-CoV-2 reinfection both from the agent and host points of view, and discusses its implication for COVID-19 vaccine development."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Pharmacy, Hasanuddin University , 90245, Tamalanrea, Makassar, Indonesia."
          }
        ],
        "LastName": "Nainu",
        "ForeName": "Firzan",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Hasanuddin University , 90245, Tamalanrea, Makassar, Indonesia."
          }
        ],
        "LastName": "Abidin",
        "ForeName": "Rufika Shari",
        "Initials": "RS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Pharmacy, Hasanuddin University , 90245, Tamalanrea, Makassar, Indonesia."
          }
        ],
        "LastName": "Bahar",
        "ForeName": "Muh Akbar",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Division for Natural Product Technology (BPTBA), Indonesian Institute of Sciences (LIPI) , 55861, Wonosari, Indonesia."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmaceutical Biology, Pharmaceutical Institute, University of T\u00fcbingen , 72076, T\u00fcbingen, Germany."
          }
        ],
        "LastName": "Frediansyah",
        "ForeName": "Andri",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacy, BGC Trust University Bangladesh , 4381, Chittagong, Bangladesh."
          }
        ],
        "LastName": "Emran",
        "ForeName": "Talha Bin",
        "Initials": "TB"
      },
      {
        "Identifier": [
          "0000-0002-6774-9847"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare , 31311, Dhahran, Saudi Arabia."
          }
        ],
        "LastName": "Rabaan",
        "ForeName": "Ali A",
        "Initials": "AA"
      },
      {
        "Identifier": [
          "0000-0001-7469-4752"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, ICAR-Indian Veterinary Research Institute , 243122, Izatnagar, Bareilly, Uttar Pradesh, India."
          }
        ],
        "LastName": "Dhama",
        "ForeName": "Kuldeep",
        "Initials": "K"
      },
      {
        "Identifier": [
          "0000-0001-7630-8413"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Research Unit, School of Medicine, Universitas Syiah Kuala , 23111, Banda Aceh, Indonesia."
          },
          {
            "Identifier": [],
            "Affiliation": "Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala , 23111, Banda Aceh, Indonesia."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, School of Medicine, Universitas Syiah Kuala , 23111, Banda Aceh, Indonesia."
          }
        ],
        "LastName": "Harapan",
        "ForeName": "Harapan",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Hum Vaccin Immunother",
    "NlmUniqueID": "101572652",
    "ISSNLinking": "2164-5515"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "immunology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Drug Development"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "prevention & control"
      ],
      "DescriptorName": "Reinfection"
    },
    {
      "QualifierName": [
        "drug effects",
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}